Latest Regional Growth News

Orora reports a 24.6% rise in underlying EBIT to $120.8 million for H1 FY25, driven by the Saverglass acquisition and portfolio simplification, while navigating operational challenges and market headwinds.

Zenith Minerals has secured Program of Work approval to launch a new drilling campaign at its Dulcie Far North gold project, following a 40% resource increase. The company is also advancing development studies and exploring multiple new regional gold targets.

Arizona Lithium has unveiled a detailed, phased development plan for its Prairie Lithium Project, aiming to become North America’s first commercial lithium brine producer. The company targets initial production in 2025 with a modest capital outlay and scalable expansion strategy.

Cavalier Resources has successfully raised A$1.735 million through a rights issue, positioning the company to advance its Crawford Gold Project amid record gold prices and promising exploration results.

archTIS Limited reported a 12% increase in annual recurring revenue to $4 million and achieved net positive cash flow from operations, while signing a binding term sheet to acquire Direktiv’s assets, signaling strategic growth in data-centric security.

Advanced Health Intelligence Ltd has locked in a USD$4 million convertible note facility with UAE-based KOR Investments LLC, aiming to raise up to AUD$10 million to fuel its MENA expansion and reduce debt.

Streamplay Studio has completed its acquisition of North American indie game publisher Noodlecake Studios, marking a pivotal expansion in its gaming portfolio. The company also reported robust regional growth and a strong cash position, setting the stage for ambitious product launches and market penetration.

Bubs Australia has reported a strong Q2 FY25 performance with a positive EBITDA turnaround and robust revenue growth, while advancing its critical FDA clinical trial in the US.

Orthocell Limited has reported a third consecutive quarter of record revenue, driven by strong sales growth and strategic market expansions, including a key US FDA submission for its nerve repair product Remplir™.